165 related articles for article (PubMed ID: 35321187)
1. Develop a nomogram to predict overall survival of patients with borderline ovarian tumors.
Gong XQ; Zhang Y
World J Clin Cases; 2022 Mar; 10(7):2115-2126. PubMed ID: 35321187
[TBL] [Abstract][Full Text] [Related]
2. A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.
Xu XL; Cheng H; Tang MS; Zhang HL; Wu RY; Yu Y; Li X; Wang XM; Mai J; Yang CL; Jiao L; Li ZL; Zhong ZM; Deng R; Li JD; Zhu XF
Oncotarget; 2017 Jan; 8(5):8120-8130. PubMed ID: 28042955
[TBL] [Abstract][Full Text] [Related]
3. Women With Ovarian Cancer and With Fertility Preservation: A Survival Analysis Using the Surveillance, Epidemiology, and End Results Database and Construction of Nomograms to Predict Cancer-Specific Survival.
Hou YM; Yu H; Hao JT; Feng F; An RF
Front Oncol; 2022; 12():860046. PubMed ID: 35480098
[TBL] [Abstract][Full Text] [Related]
4. Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma.
Hu J; Jiao X; Zhu L; Guo H; Wu Y
BMC Cancer; 2020 Sep; 20(1):938. PubMed ID: 32993522
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics Predict Recurrence in Borderline Ovarian Tumor Patients with Fertility-Preserving Surgery.
He Y; Zhong J; Yang H; Shan N; Cheng A
Int J Gen Med; 2022; 15():2197-2206. PubMed ID: 35250297
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and application of a nomogram model for prognostic risk prediction in patients with epithelial ovarian cancer].
Li Z; Cai XW; Yan P; Zhou D; He MM; Deng L; Wang YZ; Liang ZQ
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):190-197. PubMed ID: 35385956
[No Abstract] [Full Text] [Related]
7. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract][Full Text] [Related]
8. Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients.
Bai G; Zhou Y; Rong Q; Qiao S; Mao H; Liu P
J Inflamm Res; 2023; 16():1227-1241. PubMed ID: 37006810
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
Barlin JN; Yu C; Hill EK; Zivanovic O; Kolev V; Levine DA; Sonoda Y; Abu-Rustum NR; Huh J; Barakat RR; Kattan MW; Chi DS
Gynecol Oncol; 2012 Apr; 125(1):25-30. PubMed ID: 22155261
[TBL] [Abstract][Full Text] [Related]
10. Nomogram to predict the probability of relapse in patients diagnosed with borderline ovarian tumors.
Obermair A; Tang A; Kondalsamy-Chennakesavan S; Ngan H; Zusterzeel P; Quinn M; Carter J; Leung Y; Janda M
Int J Gynecol Cancer; 2013 Feb; 23(2):264-7. PubMed ID: 23295940
[TBL] [Abstract][Full Text] [Related]
11. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Prognostic Prediction Model for Postoperative Ovarian Sex Cord-Stromal Tumor Patients.
You D; Zhang Z; Cao M
Med Sci Monit; 2020 Sep; 26():e925844. PubMed ID: 32943602
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte-to-monocyte ratio after primary surgery is an independent prognostic factor for patients with epithelial ovarian cancer: A propensity score matching analysis.
Hu Q; Shen G; Li Y; Xie Y; Ma X; Jiang L; Lv Q
Front Oncol; 2023; 13():1139929. PubMed ID: 37035193
[TBL] [Abstract][Full Text] [Related]
14. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
Yang HM; Lou G
Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
[No Abstract] [Full Text] [Related]
15. A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
Tang X; Zhang X; Liu X; Zheng T; Hua K; Qiu J
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():256-262. PubMed ID: 33259994
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonographic markers and preoperative CA-125 to distinguish between borderline ovarian tumors and stage I ovarian cancer.
Zacharakis D; Thomakos N; Biliatis I; Rodolakis A; Simou M; Daskalakis G; Bamias A; Antsaklis A
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):285-92. PubMed ID: 23193945
[TBL] [Abstract][Full Text] [Related]
17. Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.
Ouldamer L; Bendifallah S; Naoura I; Body G; Uzan C; Morice P; Ballester M; Daraï E
Hum Reprod; 2016 Aug; 31(8):1732-7. PubMed ID: 27496944
[TBL] [Abstract][Full Text] [Related]
18. A prognostic nomogram for women with primary ovarian signet-ring cell carcinoma.
Wang X; Ke X; Min J
Ann Transl Med; 2021 Apr; 9(7):525. PubMed ID: 33987223
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of factors related to the prognostic benefit of neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer].
Wang DF; Zhang GN; Peng CR; Shi Y; Shi XW
Zhonghua Fu Chan Ke Za Zhi; 2021 Jun; 56(6):385-392. PubMed ID: 34154313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
